Caption Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,493
Closed -$332K 1550
2025
Q4
$229K Buy
+10,493
New +$218K ﹤0.01% 1360
2025
Q1
Sell
-3,964
Closed -$122K 1507
2024
Q4
$122K Buy
+3,964
New +$132K ﹤0.01% 1324
2024
Q3
Sell
-4,500
Closed -$178K 1266
2024
Q2
$178K Buy
+4,500
New +$146K ﹤0.01% 967
2023
Q4
Sell
-8,200
Closed -$257K 1324
2023
Q3
$257K Buy
+8,200
New +$258K ﹤0.01% 1062
2022
Q4
Sell
-2,956
Closed -$106K 1276
2022
Q3
$106K Buy
+2,956
New +$123K ﹤0.01% 1325

Other funds holding ATEX

Caption Management's ATEX Position: Q1 2026 in Review

Caption Management sold out of Anterix (ATEX) in Q1 2026, closing a stake of 10,493 shares — an estimated $332K sold.

Caption Management first reported a position in ATEX in Q3 2022 and held it in 5 quarters. The position peaked at $257K in Q3 2023. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Caption Management reported no remaining Anterix position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 10,493 Anterix shares in Q1 2026, an estimated $332K.
  • Caption Management first reported a position in Anterix in Q3 2022 and held it in 5 quarters.
  • Caption Management's Anterix position peaked at $257K in Q3 2023.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.